Cann Group Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Peter Koetsier

Chief Executive Officer (CEO)

AU$442.2k

Compensación total

Porcentaje del salario del CEO	35.0%
Permanencia del CEO	1.3yrs
Participación del CEO	n/a
Permanencia media de la dirección	less than a year
Promedio de permanencia en la Junta Directiva	2.6yrs

Actualizaciones recientes de la dirección

Recent updates

A Piece Of The Puzzle Missing From Cann Group Limited's (ASX:CAN) Share Price

Dec 27

Cann Group (ASX:CAN) Is Making Moderate Use Of Debt

May 18

Shareholders May Be A Bit More Conservative With Cann Group Limited's (ASX:CAN) CEO Compensation For Now

Nov 03

Here's Why We're Not Too Worried About Cann Group's (ASX:CAN) Cash Burn Situation

Feb 23

What Type Of Returns Would Cann Group's(ASX:CAN) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

Nov 25

One Forecaster Is Now More Bearish On Cann Group Limited (ASX:CAN) Than They Used To Be

Nov 25

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Peter Koetsier en comparación con los beneficios de Cann Group?
Fecha	Compensación total	Salario	Ingresos de la empresa
Dec 31 2023	n/a	n/a	-AU$29m
Sep 30 2023	n/a	n/a	-AU$32m
Jun 30 2023	AU$442k	AU$155k	-AU$34m

Compensación vs. Mercado: La compensación total ($USD285.19K) de Peter está en línea con el promedio de empresas de tamaño similar en el mercado Australian ($USD289.12K).

Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de Peter con los resultados de la empresa.

CEO

Peter Koetsier

1.3yrs

Permanencia

AU$442,188

Compensación

Mr. Peter Koetsier is Chief Executive Officer of Cann Group Limited from January 16, 2023. Mr. Koetsier brings to Cann more than 30 years of general management, marketing and commercial leadership roles wi...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Peter Koetsier	Chief Executive Officer	1.3yrs	AU$442.19k	sin datos
Tony Di Pietro	CFO & Joint Company Secretary	no data	sin datos	sin datos
Steven Notaro	Head of Legal and Regulatory Affairs & Joint Company Secretary	less than a year	AU$204.01k	sin datos

0.3yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de CAN no se considera experimentado ( 0.3 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Douglas Rathbone	Independent Non-Executive Director	9.1yrs	AU$65.00k	0.82% A$ 223.0k
Julian Chick	Non-Executive Chairman	1.5yrs	AU$46.39k	sin datos
Jennifer Pilcher	Non-Executive Director	3.6yrs	AU$80.00k	0.029% A$ 7.7k
Robert Barnes	Non-Executive Director	1.6yrs	AU$49.81k	sin datos

2.6yrs

Permanencia media

Junta con experiencia: La junta directiva de CAN no se considera experimentada (2.6 años de permanencia promedio), lo que sugiere una nueva junta directiva.

Cann Group Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

Cann Group Limited Appoints Tony Di Pietro as Joint Company Secretary of Head of Legal and Regulatory Affairs

Cann Group Limited Announces Resignation of Deborah Ambrosini as Chief Financial Officer, Effective December 22, 2023

Cann Group Limited, Annual General Meeting, Oct 26, 2023

Cann Group Limited Announces Chief Executive Officer Changes

Less than half of directors are independent

Cann Group Limited Appoints Julian John Chick as Director

Recent updates

New major risk - Financial position

Cann Group Limited Appoints Tony Di Pietro as Joint Company Secretary of Head of Legal and Regulatory Affairs

A Piece Of The Puzzle Missing From Cann Group Limited's (ASX:CAN) Share Price

Cann Group Limited Announces Resignation of Deborah Ambrosini as Chief Financial Officer, Effective December 22, 2023

Cann Group Limited has filed a Follow-on Equity Offering in the amount of AUD 0.3756 million.

Cann Group Limited, Annual General Meeting, Oct 26, 2023

Full year 2023 earnings released: AU$0.091 loss per share (vs AU$0.079 loss in FY 2022)

New minor risk - Financial data availability

Cann Group Limited has completed a Follow-on Equity Offering in the amount of AUD 11.658446 million.

Cann Group Limited Provides Revenue Guidance for the Year Ended June 30, 2023

Cann Group (ASX:CAN) Is Making Moderate Use Of Debt

First half 2023 earnings released: AU$0.053 loss per share (vs AU$0.028 loss in 1H 2022)

Cann Group Limited Announces Preliminary Results from Their Phase 3 Clinical Trail

Cann Group Limited Announces Chief Executive Officer Changes

Cann Group Limited Announces Final Clinical Trial Participant Completes Study

Less than half of directors are independent

Cann Group Limited Appoints Julian John Chick as Director

Cann Group Limited Announces Resignation of Peter Crock as CEO

Cann Group Limited Meets its Enrolment Target for Phase III Clinical Trial of Low-Dose Satipharm CBD Capsules for Short-Term Sleep Disturbance

Cann Group Limited Announces Executive Changes

Cann Group Limited Appoints Robert Barnes & Julian Chick to the Board

Cann Group Limited Announces Resignation of John Sharman as Director

Cann Group Limited, Annual General Meeting, Oct 25, 2022

Full year 2022 earnings released: AU$0.079 loss per share (vs AU$0.098 loss in FY 2021)

Cann Group Limited Announce Therapeutic Goods Administration Grants Cann GMP License to Manufacture Therapeutic Goods

Cann Group Limited Receives Second Payment from Victorian Government's Regional Jobs Fund Program

Less than half of directors are independent

Office of Drug Control Grants Permit for Manufacture of Medicinal Cannabis Products to Cann Group Limited

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Cann Group Limited Announces Resignation of Mr. Geoffrey Pearce as Non-Executive Director

Cann Group Limited Announces Cann to Begin Recruitment for CBD Phase 3 Clinical Trial

Rua Bioscience Limited (NZSE:RUA) agreed to acquire 8.36% stake in Zalm Therapeutics Ltd from Cann Group Limited (ASX:CAN) for NZD 10 million.

Shareholders May Be A Bit More Conservative With Cann Group Limited's (ASX:CAN) CEO Compensation For Now

Chief Financial Officer Greg Bullock has left the company

Full year 2021 earnings released: AU$0.097 loss per share (vs AU$0.12 loss in FY 2020)

Cann Group Limited Revises Revenue Guidance for the Year 2021

Cann Group Limited (ASX:CAN) completed the acquisition of Satipharm Ltd, Satipharm AG and Phytotech Therapeutics Ltd from Harvest One Cannabis Inc. (TSXV:HVT)

Cann Group Limited, Olivia Newton-John Cancer Research Institute and Austin Health Partnered in A Clinical Tria to Assess Medicinal Cannabis for Symptom Management in People with Advanced Cancer

Cann Group Limited (ASX:CAN) entered into a definitive sale agreement to acquire Phytotech Therapeutics Ltd from Harvest One Cannabis Inc. (TSXV:HVT).

First half 2021 earnings released: AU$0.05 loss per share (vs AU$0.06 loss in 1H 2020)

Here's Why We're Not Too Worried About Cann Group's (ASX:CAN) Cash Burn Situation

Cann Group Limited (ASX:CAN) signed a share sale agreement to acquire Satipharm Ltd from Harvest One Cannabis Inc. (TSXV:HVT) for CAD 4 million.

New 90-day high: AU$0.78

Australis Capital Inc. and Cann Group Limited Sign Agreement

Price target lowered to AU$1.12

Cann Group Limited Receives Initial 19,000 Unit Order for Europe

What Type Of Returns Would Cann Group's(ASX:CAN) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

One Forecaster Is Now More Bearish On Cann Group Limited (ASX:CAN) Than They Used To Be

Analysts update estimates

New 90-day high: AU$0.51

Deputy Chairman recently bought AU$55k worth of stock

An unknown buyers acquired 11.84% stake in Cann Group Limited (ASX:CAN) from Aurora Cannabis Inc. (TSX:ACB).

New 90-day low: AU$0.38

Cann Group Limited(ASX:CAN) dropped from S&P Global BMI Index

Deputy Chairman recently bought AU$79k worth of stock

Full year earnings released - AU$0.12 loss per share

New 90-day low - AU$0.45

Cann Group Limited has completed a Follow-on Equity Offering in the amount of AUD 25.9 million.

New 90-day low - AU$0.46

Cann Group Limited has completed a Follow-on Equity Offering in the amount of AUD 14.3 million.

New 90-day low - AU$0.72

Cann Group Limited(ASX:CAN) dropped from S&P/ASX All Ordinaries Index

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Miembros de la Junta